The U.S. Food and Drug Administration today approved Arcapta Neohaler (indacaterol inhalation powder) for the long term, once-daily maintenance bronchodilator treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD) including...
The U.S. Food and Drug Administration has announced that the United States District Court for the Eastern District of California, Sacramento Division, entered a consent decree of permanent injunction against John C. ivermectin for horses ticks Virtue, doing business...
